Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functions needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re ready to take on the world’s diseases, ailments and adversity.

The Backbone of our Innovation

The Dova Board brings impressive experience to the table, bright minds from across the spectrum of relevant disciplines helping to illuminate the path forward for our pharmaceutical solutions.

Roger A. Jeffs

Joined Dova Board: May 2017

Dr. Jeffs is the former President and Co-Chief Executive Officer of United Therapeutics Corporation, which he joined in 1998. During Dr. Jeffs’ career at United Therapeutics, he oversaw the company’s global clinical, commercial, manufacturing, regulatory, pharmacovigilance, and business development efforts. Prior to joining United Therapeutics, Dr. Jeffs served as the worldwide clinical leader of the Infectious Disease Program at Amgen, Inc. Prior to Amgen, he was a member of the clinical research team at Burroughs Wellcome & Company. He currently serves on the board of Axsome Therapeutics. Dr. Jeffs received his B.S. in Chemistry from Duke University and his Ph.D. in Pharmacology from the University of North Carolina.